Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026
Same author

Development of a Computed Tomography Enterography Based Radiomics Model to Characterize Inflammation, Fibrosis and Smooth Muscle Thickening in Stricturing Crohn's Disease.

The American journal of gastroenterology·2026
Same author

Development of Mesothelioma in Organ Transplant Recipients: A Comprehensive Study of 10 Cases.

Archives of pathology & laboratory medicine·2026
Same author

Air Change Setbacks and Surgical Outcomes and Energy Use in Operating Rooms.

JAMA surgery·2026
Same author

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Strategies to meaningfully reduce healthcare sector emissions in pulmonary, critical care, and sleep practice: an official American Thoracic Society Workshop Report.

Annals of the American Thoracic Society·2026

Related Experiment Videos

Update in nonneoplastic lung diseases.

Ilyssa O Gordon1, Nicole Cipriani, Qudsia Arif

  • 1Department of Pathology, University of Chicago, Chicago, Illinois 60637, USA.

Archives of Pathology & Laboratory Medicine
|August 1, 2009
PubMed
Summary
This summary is machine-generated.

Advances in understanding nonneoplastic lung diseases like pulmonary hypertension and asthma impact pathology. Pathologists must integrate new pathophysiological insights and evolving classification systems for accurate diagnosis and treatment.

Related Experiment Videos

Area of Science:

  • Pulmonary Pathology
  • Respiratory Medicine
  • Disease Pathophysiology

Background:

  • Nonneoplastic lung diseases encompass a spectrum of disorders including asthma, interstitial lung disease, and pulmonary hypertension.
  • Recent discoveries in disease pathophysiology offer potential improvements in diagnosis, therapy, and prognosis.
  • Practicing pathologists require updated knowledge on how these advances affect patient care.

Purpose of the Study:

  • To review current progress in understanding the pathophysiology of pulmonary alveolar proteinosis, idiopathic pulmonary hemosiderosis, and pulmonary arterial hypertension.
  • To present updated classification systems for pulmonary hypertension, asthma, and interstitial lung disease.
  • To correlate these advancements with the practice of pulmonary pathology.

Main Methods:

  • Literature review utilizing PubMed (National Library of Medicine).
  • Analysis of primary material from the authors' institution.

Main Results:

  • Enhanced understanding of pulmonary alveolar proteinosis, pulmonary hypertension, and idiopathic hemosiderosis pathophysiology may alter the surgical pathologist's role.
  • Immunohistochemistry and molecular techniques may become essential for assessing novel disease markers.
  • Evolving classification systems for interstitial lung disease, asthma, and pulmonary hypertension necessitate consideration of clinicopathologic context.

Conclusions:

  • Pathologists must adapt to new diagnostic tools and classifications in nonneoplastic lung diseases.
  • Integration of pathophysiological knowledge and clinicopathologic correlation is crucial for accurate diagnoses.
  • The practice of pulmonary pathology is evolving with advances in understanding respiratory diseases.